RBMX and esophageal cancer: The results showed that COL4A1, DEK, GINS1, HPCAL1, KIF4A and RBMX were significantly increased in esophageal cancer tissues and decreased in the combined treatment group, suggesting that are potential prognostic markers (Supplementary Fig. 6A).